ClinicalTrials.gg
RecruitingNCT07743424Updated Sep 11, 2026

Effect of Trans-spinal Electromagnetic Neuromodulation in Treatment of Patients With Discogenic Lumbosacral Radiculopathy

An interventional study of Trans-spinal Electromagnetic Neuromodulation and Conventional physical therapy in Lumbar Radiculopathy and Discogenic Lumbosacral Radiculopathy, sponsored by Yara Aboelazm Abd Elaziz Mohamed. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Yara Aboelazm Abd Elaziz Mohamed · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

Purposes of the study

To investigate the effect of adding Trans-spinal Electromagnetic Neuromodulation to conventional physical therapy in patients with Discogenic Lumbosacral Radiculopathy

Read the detailed description

Patients will be randomized into either Trans-spinal Electromagnetic Neuromodulation group or Conventional physical therapy group. Patients will receive the intervention for six weeks. Outcomes will be assessed at baseline and post-intervention.

02

Conditions studied

  • Lumbar Radiculopathy
  • Discogenic Lumbosacral Radiculopathy

Browse trials for

03

In context

Radiculopathy

483 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 373 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

This is the only study on the registry with Yara Aboelazm Abd Elaziz Mohamed as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. patient age range from 20 -40 from both sexes.
  2. Unilateral chronic lumbosacral radiculopathy confirmed by neurosurgeon for more than 3 months.
  3. Unilateral paracentral or lateral intervertebral disc herniation confirmed by MRI .
  4. one of the following:

    1. H- reflex amplitude side to side difference 67% in absence of latency difference.
    2. H- reflex amplitude side to side difference smaller than 50% in presence of latency difference.

c - Side to side H- reflex latency difference more than 1 msec. d- Prolonged H-reflex latency more than 30 msec.

Exclusion criteria

Exclusion Criteria:

  1. Hypertension
  2. Diabetes.
  3. Lumbar canal stenosis
  4. Pervious surgeries
  5. Scoliosis
  6. Kyphosis
  7. Spinal fracture
  8. Bilateral symptoms.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Trans-spinal Electromagnetic Neuromodulation + Conventional physical therapy

    Patients in this group will receive Trans-spinal Electromagnetic Neuromodulation + Conventional physical therapy

    Other: Trans-spinal Electromagnetic Neuromodulation · Other: Conventional physical therapy

  • Active comparator
    Conventional physical therapy

    Patients in this group will receive Conventional physical therapy

    Other: Conventional physical therapy

Interventions

  • OtherTrans-spinal Electromagnetic Neuromodulation

    Trans-spinal electromagnetic neuromodulation will be applied for 15 minutes on the affected segment

  • OtherConventional physical therapy

    Conventional physical therapy consisting of: Hot pack on lumbar spine. Neurodynamic mobilization. Rotatory mobilization and rotatory manipulation for lumbar spine. Core stability exercises.

06

What researchers measure

Primary outcomes

  1. Pain

    Numeric Pain Rating Scale (0-10)

    Time frame: Change from Baseline pain at 6 weeks

  2. Disability

    Oswestry disability index (0-100%)

    Time frame: Change from Baseline disability at 6 weeks

  3. Straight leg raise test

    Straight leg raise test

    Time frame: Change from Baseline straight leg raise test at 6 weeks

  4. H-reflex side-to-side amplitude (H/H) ratio

    by EMG unit

    Time frame: Change from Baseline H-reflex side-to-side amplitude (H/H) ratio at 6 weeks

  5. Sensory tactile threshold

    by EMG unit

    Time frame: Change from Baseline Sensory tactile threshold at 6 weeks

  6. Motor evoked potential

    by EMG unit

    Time frame: Change from Baseline motor evoked potential at 6 weeks

07

Study locations

1 of 1 sites recruiting
  • Outpatient Clinic at the Faculty of Physical Therapy Cairo
    Giza, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07743424
Lead sponsor
Yara Aboelazm Abd Elaziz Mohamed
Responsible party
Yara Aboelazm Abd Elaziz Mohamed (MSc, Cairo University) — Sponsor-investigator
First posted
Aug 3, 2026
Start date
Sep 10, 2026
Primary completion
Sep 10, 2026
Completion
Feb 10, 2027 (estimated)
Last update
Sep 11, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion